Table 3.
Group | Liver index | Hydroxyproline (μg·g−1) |
---|---|---|
NC | 3.15 ± 0.12 | 108.54 ± 8.54 |
CCl4-treatment | 4.73 ± 0.24 b | 481.63 ± 23.11 b |
CCl4+RPRAE (100 mg/kg b.w.) | 4.31 ± 0.25 c | 361.57 ± 23.07 d |
CCl4+RPRAE (200 mg/kg b.w.) | 3.91 ± 0.19 d | 239.11 ± 16.74 d |
CCl4+RPRAE (300 mg/kg b.w.) | 3.43 ± 0.12 d | 156.37 ± 12.14 d |
CCl4+Bifendate (100 mg/kg b.w.) | 3.57 ± 0.19 d | 194.08 ± 18.62 d |
b P < 0.01, compared with NC group; c P < 0.05, d P < 0.01, compared with CCl4-treated group.
Note: NC (normal control).